Navigation Links
Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
Date:10/10/2007

reported net loss of $144 million in the same period last year. The increase in the fourth quarter loss related primarily to the D&PL IPR&D charge. For fiscal year 2007, Monsanto reported net income of $993 million which was significantly higher than net income of $689 million in fiscal year 2006.

Loss per share for the fourth quarter was $(0.39) on an as-reported basis, and was $(0.18) on an ongoing basis. Earnings per share (EPS) for fiscal year 2007 were $1.79 on an as-reported basis, and $2.00 on an ongoing basis. (For a reconciliation of ongoing EPS, see page 1. See note 2 for a discussion of ongoing EPS.) As reported EPS results for both periods reflect the effect of discontinued operations for the Stoneville(R) and NexGen(R) cottonseed businesses, as well as the D&PL IPR&D charge.

The company's results also reflect a lower tax rate for continuing operations in 2007 primarily resulting from the resolution of several tax audits and the company's ability to use net operating loss carry forwards in Argentina. These positive factors were partially offset by approximately 4 points attributable to non-deductible IPR&D charges associated with the company's recent acquisition of D&PL.

Cash Flow

For fiscal year 2007, net cash provided by operating activities was $1.9 billion, compared with $1.7 billion in the same period in 2006. Net cash required by investing activities was $1.9 billion in fiscal year 2007, compared with net cash required of $625 million for the same period last year. As a result, free cash flow was a use of $57 million for fiscal year 2007, compared with a source of $1 billion in fiscal year 2006. (For a reconciliation of free cash flow, see note 2.) Free cash flow in fiscal year 2007 reflected higher net income and higher spending on acquisitions when compared with fiscal year 2006. Net cash required by financing activities was $583 million for fiscal year 2007, compared with net cash required of $117 million last year.

'/>"/>
SOURCE Monsanto
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Privacy, trust still the biggest barriers to electronic record sharing
2. Visions: Wade offers straight talk on e-medical records
3. Portal to e-records boosts care at Childrens Hospital
4. Yasnoff: Wisconsin should invest in health record bank
5. Doyle seeks $30M for e-medical record adoption
6. Impact of e-medical records will be felt at home
7. Epic responds to critics of electronic record installation
8. GE Healthcare launches hybrid electronic record
9. Careful with that electronic health record, Mr. Leavitt
10. Wisconsin companies reach deal on electronic health records
11. Tommy Thompson says capital needed for electronic health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... Total impact of NC,s biotechnology sector is $45....LE PARK, N.C., Nov. 20 ...n its expanding biotechnology enterprise during th...ceeds $45 billion, according to data released toda... , Norris Tolson, president and CEO of the Bio...
(Date:11/20/2008)... SAN DIEGO, Nov. 20 Neur...ced today that Kevin Gorman, President and Chief,...e presenting at the 20th,Annual Piper Jaffray Hea... "fireside chat" presentation takes place Tuesday,.../10:30 a.m. Pacific Time (PT). The,presentation w...
(Date:11/20/2008)... LENEXA, Kan., Nov. 20 KansasBio a...itiative to promote the region,s human,health-car...re drug,development continuum. Called the Nationa... the alliance comprises companies across Kansas an...t many of the nation,s preferred resources,for dr...
(Date:11/20/2008)... LONGMONT, Colo., Nov. 20 MicroPha...unced it has concluded its latest round,of financ...ion. Investors in,this round were a combination ... have come from private investors. , MicroP...ete the validation,and launch preparation of thei...
Breaking Biology Technology:North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 3North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 4North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 5National Drug Development Accelerator Launched 2MicroPhage Closes Latest Financing 2
... technology managers in healthcare received a heav...eld during the opening session of WTN Media,s Dig...ich is being held May 3 and 4 at the Fluno Center ...tured an opening panel discussion in which there w...he industry has come with information systems. Nor...
...lanning will accomplish more in preparing for the ...than will any reliance on information technology, ...rence were told. , ,Panelists talked about being ...detect and mitigate the effects of a flu pandemic,... disruptions before running its course. , ,For hea...
...site in your industry is a noble goal, a far more ... ,The best means of measuring your web site,s popu...t is, the number and quality of other web sites li...k to your web site, it,s a vote of confidence in y...idence is inherited by search engines which reward...
...are of managing liability in identity theft cases ...,s Digital Healthcare Conference, and healthcare p...od it would be. , ,Using a hypothetical case of id...s from Michael Best & Friedrich demonstrated how...emselves in even when they take steps to prevent s...
Other Biology Technology:Digital Healthcare Conference starts on a realistic note 2Digital Healthcare Conference starts on a realistic note 3IT may take a back seat in fighting avian flu 2IT may take a back seat in fighting avian flu 3IT may take a back seat in fighting avian flu 4Link Popularity: The Internet's 'In' Crowd 2Link Popularity: The Internet's 'In' Crowd 3Managing the nightmare of identity theft 2Managing the nightmare of identity theft 3Managing the nightmare of identity theft 4
(Date:11/20/2008)...swire/ -- DigitalPersona, Inc., the,leader in fin...alPersona,Personal 4.0, an easy-to-use identity p...nd business users. DigitalPersona Personal 4.0 is ...rics, letting people use their fingerprints to,ac...shopping, and other Web,sites -- to provide a cri...
(Date:11/20/2008)... A team led by Thomas Schulthess of the U.S. Depar...ceived the prestigious 2008 Association for Comput...er attaining the fastest performance ever in a sci... is group leader of ORNL,s Computational Materials... director of the Swiss National Supercomputing Cen...
(Date:11/20/2008)...n ageing population, and turning research into com...lion ($30.4 million) investment announced today by...uncil (EPSRC), Technology Strategy Board (TSB) and...h Council (BBSRC). , This new investment will cr...ientific breakthroughs have already been achieved....
(Date:11/19/2008)...rms, sponges, jellyfish - have the simplest eyes t... a photoreceptor cell and a pigment cell. These mi...yes, suggested by Charles Darwin as the first eyes...mages but allow the animal to sense the direction ...the swimming towards light exhibited by many zoopl...
Breaking Biology News(10 mins):DigitalPersona Places Identity Protection at People's Fingertips 2DigitalPersona Places Identity Protection at People's Fingertips 3ORNL supercomputer simulation wins prize for fastest-running science application 2ORNL supercomputer simulation wins prize for fastest-running science application 3£20 million to fight virtual crime and treat our aging population 2£20 million to fight virtual crime and treat our aging population 3Uncovering secrets of life in the ocean 2American Laser Centers Names Bill Van Huis as Chief Revenue Officer 12587 1American Laser Centers Names Bill Van Huis as Chief Revenue Officer 12587 2Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 1Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 2Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 3Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 12581 4Strativa Pharmaceuticals a Division of Par Pharmaceutical Announces the Discontinuation of the Development Program for Pafuramidine 3479 1Strativa Pharmaceuticals a Division of Par Pharmaceutical Announces the Discontinuation of the Development Program for Pafuramidine 3479 2Strativa Pharmaceuticals a Division of Par Pharmaceutical Announces the Discontinuation of the Development Program for Pafuramidine 3479 3Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 1Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 2Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 3Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 4Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 5Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 12579 6
...n body deal with injury better than others. A fles...ou are otherwise healthy, both will heal. The prog...t so clear-cut. , It has long been thought that ca... self-renewal and repair, impeding the chances of ...nt evidence suggests that the heart might harbor s...
...oday announced the grant of a major patent, US # 6...k Office on microarray products allowing the speci...icing, covering microarrays optimised for the disc...nt protects the probe configuration of a unique se...ch splice variant. There are many applications for...
...esults in irreversible damage to the heart that ca...ge results from the limited ability of the myocard... and colleagues from Tufts University now document... of human bone marrow–derived stem cells with ther... following myocardial infarction. , In their study...
...tal ball. A new approach to predict whether a drug...s best could get antibiotics to market faster and ...s. , In recent years, scientists worldwide have so...to combat bad bugs. Bacteria are increasingly adep.... , Yet designing and testing new antibiotics can...
Other Biology News:Heart repair gets new muscle 2Products containing specific probes for detecting alternative splice forms protected 2New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 2New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 3New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 4
Finnigan LTQ FT from Thermo Scientific
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
Biology Products: